关键词：Sector Development;Healthcare Reform;Market Drivers
摘 要：With over 5,900 enterprises and revenue of RMB1.5bn as of 2011, China’s pharmaceutical manufacturing sector contributes to around 13% of the total healthcare services market in China, which itself made up around 5.5% of the country’s GDP in the year. Sector revenue have been growing at a doubledigit rate exceeding 24% during the 2000s, driven by strong demand growth. Foreign demand for the sector’s products made up around 33% of the output volume in 2011, but has a decreasing share in total. Domestic demand is growing faster, particularly with the price cuts of pharmaceuticals products in 2011 undertook by the government. This has resulted in slower growth of the pharmaceutical retail sector, while drug manufacturers enjoyed a faster sales growth compared to the previous years.
目 录：

I. Sector Overview

1. Main Sector Indicators

2. Sector Forecasts

3. Medicines Output

4. Exports and Imports

5. Sales Revenue

6. Retail of Medicines

7. Per Capita Annual Cash Consumption Expenditure

8. Medical Care Insurance

9. Price Indices

10. Major Segments

11. Investment in Fixed Assets

12. Government Regulations

II. Major Players

1. Top 10 Players

2. Yangtze River Pharmaceutical Group

3. Harbin Pharmaceutical Group

4. Xiuzheng Pharmaceutical Group

5. North China Pharmaceutical Group Corporation

III. Regional Distribution

1. Average Per Capita Cash Expenditure for Healthcare

Services in 2011